Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Corcept Therapeutics Inc (NASDAQ:CORT)

5.18
Delayed Data
As of Aug 28
 +0.11 / +2.17%
Today’s Change
2.59
Today|||52-Week Range
7.67
+72.67%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Revenue and IncomeNet Revenues7.3M9.0M10.1M12.0M
 
 
 
 
 
Cost of Goods Sold196.0K221.0K262.0K382.0K
 
 
 
 
 
Depreciation And Amortization39.0K37.0K40.0K57.0K
 
 
 
 
 
 
Operating ExpensesGross Income7.0M8.8M9.8M11.5M
 
 
 
 
 
General Expenses12.2M11.8M13.8M12.7M
 
 
 
 
 
Research And Development3.0M3.8M4.4M3.3M
 
 
 
 
 
Total Operating Expenses12.4M12.1M14.1M13.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-5.1M-3.1M-4.0M-1.2M
 
 
 
 
 
Interest Expense On Debt895.0K800.0K762.0K737.0K
 
 
 
 
 
Other Expenses-8.0K-18.0K-38.0K-33.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-6.0M-3.9M-4.8M-1.9M
 
 
 
 
 
Net Income-6.0M-3.9M-4.8M-1.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS101.1M101.3M101.9M107.9M
 
 
 
 
 
Shares To Calculate EPS Diluted101.1M101.3M101.9M107.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.06-$0.04-$0.05-$0.02
 
 
 
 
 
EPS Diluted-$0.06-$0.04-$0.05-$0.02